MedTech Investing Conference IBF Conferences – International Business Forum LifeScience Alley™
Agenda Advisory Board Sponsors Companies Attending Speakers Hotel Register 2010 Presentations About Us

Register Now!



  • 2010
  • 2009
  • 2008

View Full Agenda 2010 Conference Agenda



Navigating the Changing MedTech Landscape:
Investment Trends, Regulatory Issues & Global Opportunities
Wednesday, May 19      DEVICE SPECIALTY DAY
   
1:00 - 2: 00 pm Registration
2:00 - 5: 00 MedTech Vertical Markets
Attendees have the opportunity to participate in interactive break-out sessions focused
on the hottest medical device vertical markets. You will hear first-hand from each industry’s leading physicians, scientists, CEOs, corporates and VCs.
Track 1      Ophthalmology Innovation
                 Track Chair: Richard Lindstrom, MD, Founder & Attending Surgeon –
                       Minneapolis Eye Consultants
2:00 - 2:15 Welcome & Lay of the Land
A general overview of the ophthalmology sector and data on investment trends.

Richard Lindstrom, MD, Founder & Attending Surgeon – Minneapolis Eye Consultants
Douglas Fisher, MD, Principal – InterWest Partners
2:15 - 3:15 Clinical/Physician Presentations: Trends & Needs in Medical Innovation

Anterior Segment Surgeon Perspective
Richard Lindstrom, MD, Founder & Attending Surgeon, Minnesota Eye Consultants
Adjunct Professor Emeritus, University of Minnesota, Department of Ophthalmology

Posterior Segment Surgeon Perspective
Eugene DeJuan MD, Founder & ViceChairman - ForSight Labs

Primary Care Specialist Perspective
Scott Hauswirth, OD - FAAO, Consultative Optometrist - Minnesota Eye Consultants Faculty at the Illinois College of Optometry and the Southern California College of Optometry

Care Center of Excellence CEO Perspective
Bill Kenney, CEO Phillips Eye Institute
3:15 - 3:45 Afternoon Networking Break
3:45 - 4:15 Venture Capital Panel Discussion
This panel will take a deeper dive into where the investment opportunities are and how to address the challenge of getting these device(s) to market.

MODERATOR:
Douglas Fisher, MD, Principal – InterWest Partners

PANELISTS:
Mike Gertner, Adjunct Partner – Essex Woodlands Health Ventures
Nick Pliam, MD, PhD, Venture Partner – Bay City Capital
Steven D. Weinstein, Managing Director – Novartis Venture Fund
4:15 - 4:45 Meeting the Needs of the Market:
Evaluating the cost/value proposition to patients as consumer

Paul Ehlen, CEO
Precision Lens

Jim Tiffany, MBA, CEO
TLCVision
4:45 - 5:30 Company Showcase
Ophthalmology start-ups will have 15 minutes each to describe how they are treating ophthalmic conditions with innovative medical devices.

Ralph Chu,                     Yichieh Shiuey, MD, Founder
Revision                           KeraMed

Ed Peterson, CEO
AcuFocus
Track 2              Bariatric Innovation
                         Track Chair: David Milne, Managing Partner - SV Life Sciences
2:00 - 2:05 Welcome & Lay of the Land
A general overview of the bariatric/obesity space and data on investment trends.

David Milne, Managing Partner
SV Life Science Partners
2:05 - 3:00 Physician Presentation
Expert physicians will provide clinical statistics on obesity and elaborate on combating this growing epidemic.

Mitchell Roslin, MD, Chief of Bariatric Surgery - Lenox Hill New York City
Aurora Pryor, MD Duke Center for Metabolic and Weight Loss Surgery
3:00 - 3:30 Afternoon Networking Breaky
3:30 - 4:30 VC / Corporate Panel
VC’s and Corporates will discuss where they see opportunities, dive further into investment trends, syndication, and addressing the challenges of getting these device(s) to market.

MODERATOR:
Jan Garfinkle, Founder & Managing Director
Arboretum Ventures

PANELISTS:
Mike Carusi, General Partner                  John Onopchenko, Founder & Managing Director
Advanced Technology Ventures                Synergy Life Science Partners

David Milne, Managing Partner               Evan M Norton, Director
SV Life Science Partners                         Abbott Ventures Inc.
4:30 - 5:30 CEO’S SPEAK OUT ON DEVELOPING DEVICES TO TREAT MORBID OBESITY & METABOLIC CONDITIONS

MODERATOR:
Mike Carusi, General Partner, Advanced Technology Ventures

PANELISTS:
Mitch Dann, Chairman                  William Murray, President & CEO
Valentx                                        ReShape Medical

Stu Randle, President & CEO
GI Dynamics
Track 3             Women’s Health Innovation
                        Track Chair: Linda Grais, Partner – InterWest Partners
2:00 - 2:05 Welcome Remarks

Linda Grais, Partner
InterWest Partners
2:05 - 2:40 Lay of the Land
A general overview of the women’s Health sector and addressing Innovation trends.

Charles Carignan, MD, President and CEO – NinePoint Medical, Inc.
2:40 - 3:30

VENTURE CAPITAL AND M&A ACTIVITY:
This panel will take a deeper dive into where the investment opportunities are, and how to address the challenge of getting these device(s) to market.

MODERATOR:
Linda Grais, MD, Partner – InterWest Partners

PANELISTS:
Michelle S. Doig, Principal, Corporate Finance – Abingworth
Stacy Feld, Director – Physic Ventures
Rakesh Mehta, Executive Director, Healthcare Investment Banking – JP Morgan Securities
3:30 - 4:00 Afternoon Networking Break
4:00 - 4:30

Case Study

Karen Talmadge, PhD
Vice President, Kyphon
Co-Founder & Chief Science Officer, Kyphon Products
Bakken Fellow, at Medtronic Spinal and Biologics
Executive Chairman – Gynesonics
5:00 - 5:30 COMPANY PRESENTATIONS
Women’s Health start-ups will describe how they are treating female health conditions with innovative devices.

Wally Danielson, CEO – Impres Medical
Bhairavi Parikh, CEO – CellScape
Darrin Uecker, President & CEO – Gynesonics
Track 4             ENT / Otolaryngology
                        Track Chair & Moderator: Tony Natale, M.D., – Prism VentureWorks
2:00 - 2:15 Welcome & Lay of the Land
A general overview of the ENT space and data on investment trends.

Tony Natale, M.D., Venture Partner
Prism VentureWorks
2:15 - 3:15 Physician Presentation:
Expert physicians will provide clinical statistics and elaborate on the growing health issues in the ENT sector.

Terry J. Garfinkle, MD, MBA, FACS,
Chief of Otolaryngology - North Shore Medical Center
Medical Director - Massachusetts General Hospital/North Shore Center for Outpatient Care

Abtin Tabaee, MD,
Director of Rhinology and Endoscopic Sinus Surgery, Department of Otolaryngology - Beth Israel Medical Center
Assistant Professor of Otolaryngology - Head and Neck Surgery – Albert Einstein College of Medicine

3:15 - 3:45 Afternoon Networking Break

3:45 - 4:30

 Company Showcase:
Otolaryngology Startups will have 10 minutes each to describe how they are combating ENT through innovation

Fred Dinger, President & CEO - ENTrigue Surgical
Lisa Earnhardt, President & CEO - Intersect ENT
Tim Herbert, President & CEO - Inspire Medical Systems

4:30 - 5:30

Corporate / VC Panel
VCs and Corporates will discuss where they see opportunities, dive further into investment trends, syndication, and addressing the challenge of getting these devices to market.

MODERATOR:
Tony Natale, M.D., Venture Partner
Prism VentureWorks

PANELISTS:
Josh Baltzell, Managing Director
Split Rock Partners

Mark Fletcher, President, ENT/NT USA
Medtronic Inc.

Mudit K. Jain, Partner,
Synergy Life Science Partners

Perry Mykleby, VP, Marketing,
Gyrus ENT, L.L.C., An Olympus Company
5:30 - 6:15
6:15 - 8:00		 Welcome Cocktail Reception
Dinner & Keynote		 Hosted By:
oppenheimer
  The New Global Economy:
Is the US losing its edge on innovation and what can be done about it? Dr. Glen Nelson will address the regulatory paths, cost of innovation, and the impact of public policy on the MedTech industry.

Dr. Glen Nelson
Chairman – GDN Holding, LLC
Former Vice Chairman – Medtronic		 glen

Thursday, May 20
7:30 - 8:30am Networking Breakfast Hosted By:
faegre
8:30 - 8:45

Welcome & Opening Remarks


Conference Chairman
Don Gerhardt, President & CEO               Carissa Stavrakos, Conference Producer
LifeScience Alley                                       International Business Forum, Inc.
8:45 - 9:00 State of the MedTech Venture Industry:
PWC MoneyTree Data on MedTech Investment Trends PWC will set the stage by presenting tailored data from the quarterly MoneyTree Report specific to investment activity in the medical device market on a regional and national level.

Thomas Montminy, Partner
PricewaterhouseCoopers LLP
9:00 - 10:00 The Lay of the Land

What specific changes/challenges are impacting Investors, CEOs & Corporates?
  • Options and Physician Relationships
  • Regulatory Path’s/Reimbursement: 510k what does it get you? Will this change the VC paradigm?
  • How do you block a PMA & keep a 510k?
MODERATOR:
Jonathan Zimmerman, Partner
Faegre & Benson, LLP

PANELISTS:.
Chad Cornell, Vice President,                    J.P. Peltier, Managing Director
Corporate Development                               Piper Jaffray & Co.
Medtronic, Inc.

B. Kristine Johnson, President                   Dennis Wahr, President & CEO
Affinity Capital Management                         Lutonix
10:00 - 10:45 The Crystal Ball:
Seasoned veterans make predictions for 2010 and beyond Will the world change and if so how?

MODERATOR:
Bill Harrington, Partner
Three Arch Partners

PANELISTS:.
Mike Carusi, General Partner,                    Peter McNerney, Partner
Advanced Technology Ventures                   Thomas McNerney & Partners

John Freund, Managing Director
Skyline Ventures
10:45 - 11:15 Networking Break
11:15 - 12:00 A View from the Trenches
Hear first-hand perspectives from leading physicians using today’s most innovative devices

MODERATOR:
John Deedrick, Managing Director
Accuitive Medical Ventures

PANELISTS:
Eugene de Juan, MD, Founder & Vice Chairman - ForSight Labs
Robert Ganz, MD, Minnesota Gastroenterology
David Schultz, MD, Founder & Medical Director – MAPS Medical Pain Clinics
12:00 - 12:45 So You Want To Go O-U.S. -- What you need to know
  • Addressing Regulatory Strategies & the major hurdles and How to go OUS
  • What are the advantages and disadvantages on using offshore manufactures?
  • Best Practices and Lessons Learned
  • The Consolidator’s View on OUS Strategies
  • Doing studies/clinical trials abroad
  • International Partnering
  • CE Mark Vs FDA Approval
  • Global Issues and Opportunities: EU, China and Brazil (friends or foes?)
MODERATOR:
Doug Mowen – Managing Director, Life Sciences Advisory
PricewaterhouseCoopers

PANELISTS:
Martha Goldberg Aronson                                        Martin Chambers, Global Vice President of Sales
Former Senior Vice President - Medtroni                       Rox Medical, Inc.

Michael Berman, Medical Device Venture Catalyst     Andrew M. Weiss, President & CEO
Berman Medical                                                        CoAxia, Inc.
12:45 - 2:00 Luncheon Hosted By: pricewaterhouse
2:00 - 3:00 Corporate Buyers and Investment Bankers Speak Out on M&A Activity

Moderator:
William Kaufman, , Partner, Corporate Finance & Transaction Group –
Oppenheimer Wolff & Donnelly, LLP

Panelists:
Kevin Davies, Managing Director & Head, Healthcare Investment Banking – RBC Capital Markets
Jeff Hoffman, Managing Director & Head of West Coast Healthcare Investment Banking –
JP Morgan Securities Inc.
Shaun Mccormick, Sr. Vice President and Chief Financial Officer – ev3
Isaac Zacharias, Director, Business Development – Boston Scientific Corporation
3:00 - 4:00 Afternoon Keynote Fireside Chat

dan GUEST SPEAKER:
Dan Schultz
Senior Vice President for Medical
Devices and Combination Products
Greenleaf Health LLC
Former CDRH Director of the FDA		 mark INTERVIEWED BY:
Mark DuVal
President
DuVal & Associates, P.A.
4:00 - 4:30 Networking Break
4:30 - 5:30 An Insider’s View of Public Policy & Regulatory Issues
Addressing physician relationships, Regulatory path’s (510k), Changing reimbursement guidelines, patent reform, Sunshine Act, Device Tax, and Comparative effectiveness

Keynote in Conversation with:
mark Mark Leahey
President & CEO
Medical Device
Manufacturers Association		 stephen Stephen J. Ubl
President & CEO
AdvaMed

Facilitated By:
kevin Kevin Wasserstein,
Managing Director
Versant Ventures
5:30 - 6:30 Cocktail Reception
6:30 Conference Adjourns
   

View Full Agenda 2009 Conference Agenda



View Full Agenda 2008 Conference Agenda